Go to the list of all blogs
Anna G's Avatar
published in Blogs
Sep 25, 2023
$HUM, $UNH, $ELV, $CI, $CNC: Managed Healthcare's +2.29% Weekly Rise!

$HUM, $UNH, $ELV, $CI, $CNC: Managed Healthcare's +2.29% Weekly Rise!


Managed Healthcare's Impressive Surge: A Deep Dive into Market Movements and Notable Tickers 🚀

🔍 Theme Description

Managed healthcare firms, including giants like $HUM, $UNH, and $ELV, are in the limelight, registering a +2.29% gain in just a week! Here’s an analysis of what’s propelling these stocks.


🏥📈 Uncover Opportunities in Managed Healthcare with AI! 💼💉

The world of managed healthcare offers intriguing prospects, and our AI-powered trading tools are your companions for success in this sector.

📉 "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" equips you with the skills to navigate markets trending down, potentially unlocking gains even in challenging conditions.

📈 If you're looking to capitalize on upward trends, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is designed to identify these opportunities, empowering you to make informed trading decisions.

With AI precision by your side, you can confidently explore the managed healthcare sector, identify trends, and make strategic moves. Stay ahead of the curve, manage risk, and potentially enhance your returns. Your journey to trading success starts here! 🚀📊

Discover the future of trading with AI expertise! 💰🤖

 

Tickers of this Group:

$CI $HUM $UNH $MOH $CNC $BIOS $ELV

💼 Industry Overview

Managed healthcare encompasses giants like Humana Inc., Unitedhealth Group Inc., and Molina Healthcare Inc., which specialize in health insurance and related services. Their chief aim? Cutting healthcare costs for consumers. With a solid growth trajectory, these stocks are setting the stage for future advancements.

💰 Market Cap

Diving into the financials, the average market cap for our theme is a whopping 111.1B. Leading the pack, $UNH boasts a 468.8B valuation, with $BIOS trailing at a still respectable 209.4M.

📈 High and Low Price Notable News

In recent times, the average weekly growth rate is 2.29%. Specifically, $HUM shines with a 4.95% spike, while $BIOS lags behind, dropping by 0.28%. Noteworthy shifts include $CI, which declined -6.36% and $CNC, dipping by -5.56%.

🎛 Volume Insights

Volume patterns reveal a -21.38% weekly average, a -42.95% monthly dip but a quarterly upswing of 97.81%. Stocks making waves? $HUM with a daily growth of 150% and Molina Healthcare, with a 355% spike!

🔢 Fundamental Analysis Ratings

A quick snapshot:

  • Valuation Rating: 49
  • P/E Growth Rating: 66
  • Price Growth Rating: 43
  • SMR Rating: 73
  • Profit Risk Rating: 37
  • Seasonality Score: 42

📊 Ticker Deep Dive

  • $CI: A bullish sign emerges as the 10-day MA goes beyond the 50-day average. Over the next month, there's an 86% chance this uptrend will continue.

  • $HUM: Yet another strong player, Humana's price surpassed its 50-day MA on September 05, 2023. History suggests a 73% probability of this uptrend lasting.

  • $UNH: Unitedhealth Group witnesses a crossover - its 50-day MA surpasses the 200-day MA. This long-term bullish indicator shows a trend shift upwards.

  • $ELV: On August 31, 2023, ELV broke its lower Bollinger Band, hinting at a potential rise. Historically, in 73% of similar scenarios, prices ascended the following month.

✨ The managed healthcare sector, with its positive outlook and strong fundamentals, is carving out a space in the limelight. Whether you're observing $HUM's uptrend or $UNH's massive market cap, the sector is ripe with opportunities for discerning traders. Keep a close watch! 📈🔥

 

Related Ticker: CI, HUM, UNH, MOH, CNC, BIOS, ELV

CI in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 03, 2026

CI broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 44 similar instances where the stock broke above the upper band. In 30 of the 44 cases the stock fell afterwards. This puts the odds of success at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 70 cases where CI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 59%.

CI moved below its 50-day moving average on September 04, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CI crossed bearishly below the 50-day moving average on August 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 09, 2026. You may want to consider a long position or call options on CI as a result. In 60 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for CI just turned positive on August 24, 2026. Looking at past instances where CI's MACD turned positive, the stock continued to rise in 30 of 49 cases over the following month. The odds of a continued upward trend are 61%.

Following a +1.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in 226 of 356 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 167 of 274 cases where CI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.741) is normal, around the industry mean (3.776). P/E Ratio (11.611) is within average values for comparable stocks, (152.490). Projected Growth (PEG Ratio) (0.764) is also within normal values, averaging (0.929). Dividend Yield (0.022) settles around the average of (0.020) among similar stocks. P/S Ratio (0.265) is also within normal values, averaging (0.595).

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating fairly steady price growth. CI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 66.95B. The market cap for tickers in the group ranges from 1.01M to 340.27B. UNH holds the highest valuation in this group at 340.27B. The lowest valued company is IHGP at 1.01M.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 65%. CLOV experienced the highest price growth at 13%, while ALHC experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was 33%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 44
Price Growth Rating: 40
SMR Rating: 72
Profit Risk Rating: 85
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
CI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of health insurance services

Industry ManagedHealthCare

Profile
Details
Industry
Managed Health Care
Address
900 Cottage Grove Road
Phone
+1 860 226-6000
Employees
67700
Web
https://www.thecignagroup.com
Interact to see
Advertisement
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.
ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.
Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.
HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.
$HUM, $UNH, $ELV, $CI, $CNC: Managed Healthcare's +2.29% Weekly Rise!